We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDOT icon
1676
Green Dot
GDOT
$746M
$277K ﹤0.01%
+14,773
New +$262K
ADPT icon
1677
Adaptive Biotechnologies
ADPT
$3.61B
$277K ﹤0.01%
41,251
-22,495
-35% -$167K
JYNT icon
1678
The Joint Corp
JYNT
$122M
$276K ﹤0.01%
+20,444
New +$300K
ALNT icon
1679
Allient
ALNT
$1.47B
$276K ﹤0.01%
6,899
-1,829
-21% -$66.5K
ANAB icon
1680
AnaptysBio
ANAB
$1.59B
$275K ﹤0.01%
+13,534
New +$274K
CNXN icon
1681
PC Connection
CNXN
$2.05B
$275K ﹤0.01%
+6,101
New +$266K
TPH
1682
DELISTED
Tri Pointe Homes
TPH
$275K ﹤0.01%
+8,370
New +$245K
PGRE
1683
DELISTED
Paramount Group
PGRE
$272K ﹤0.01%
+61,294
New +$273K
PKE icon
1684
Park Aerospace
PKE
$785M
$271K ﹤0.01%
19,615
-21,140
-52% -$280K
LFCR icon
1685
Lifecore Biomedical
LFCR
$163M
$270K ﹤0.01%
+27,911
New +$170K
CLOU icon
1686
Global X Cloud Computing ETF
CLOU
$227M
$269K ﹤0.01%
+10,366
New +$187K
VGT icon
1687
Vanguard Information Technology ETF
VGT
$138B
$269K ﹤0.01%
10,480
+6,992
+200% +$351K
UYG icon
1688
ProShares Ultra Financials
UYG
$826M
$268K ﹤0.01%
3,967
+3,213
+426% +$138K
BBUS icon
1689
JPMorgan BetaBuilders US Equity ETF
BBUS
$8.75B
$267K ﹤0.01%
4,364
+2,200
+102% +$166K
FIXD icon
1690
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
$266K ﹤0.01%
+6,024
New +$270K
EBS icon
1691
Emergent Biosolutions
EBS
$378M
$266K ﹤0.01%
+36,158
New +$335K
VBK icon
1692
Vanguard Small-Cap Growth ETF
VBK
$23.3B
$265K ﹤0.01%
+1,309
New +$285K
SOL
1693
DELISTED
Emeren Group
SOL
$265K ﹤0.01%
+69,973
New +$272K
BY icon
1694
Byline Bancorp
BY
$1.76B
$265K ﹤0.01%
14,644
-7,908
-35% -$149K
TIPT icon
1695
Tiptree Inc
TIPT
$678M
$265K ﹤0.01%
17,639
-301
-2% -$4.19K
VLUE icon
1696
iShares MSCI USA Value Factor ETF
VLUE
$9.38B
$264K ﹤0.01%
+1,039
New +$94.6K
BVS icon
1697
Bioventus
BVS
$843M
$263K ﹤0.01%
+91,045
New +$175K
NOMD icon
1698
Nomad Foods
NOMD
$1.67B
$263K ﹤0.01%
+14,995
New +$273K
NIU
1699
Niu Technologies
NIU
$209M
$263K ﹤0.01%
65,970
+13,730
+26% +$53.1K
URG
1700
Ur-Energy
URG
$489M
$262K ﹤0.01%
+249,797
New +$241K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.